Short-chain fatty acid production stimulation

Short-chain fatty acid production stimulation" refers to interventions or processes that enhance the production of SCFAs—mainly acetate, propionate, and butyrate—through microbial fermentation of dietary fibers and resistant carbohydrates in the gut[2][3][4]. SCFAs act as metabolic and signaling molecules with widespread effects on host metabolism, immune response, nervous system function, and epithelial health[3][4][5]. While stimulation of SCFA production is a key goal in nutritional and microbiome-based therapies, the term describes a biological effect and not a discrete molecular target. Instead, molecular targets involved in SCFA action (such as G protein-coupled receptors GPR41 and GPR43) are legitimate therapeutic targets for modulating SCFA signaling[1][6]. In summary, "Short-chain fatty acid production stimulation" does not represent a canonical druggable target. It is a functional or therapeutic endpoint achieved by acting on other molecular or physiological processes.

Other names

SCFA production stimulationShort-chain fatty acid production increase